Primary invasive cancer of the vagina: Outcome and complications of therapy

Australasian Radiology

Volumn 43, Issue 4, 1999, Pages 472-475

  Foroudi, F ^a   Bull, C A ^a   Gebski, V ^a  

^a WESTMEAD HOSPITAL   (Australia)

Author keywords

Chemotherapy; Radiotherapy; Surgery; Vaginal neoplasm

Indexed keywords

FLUOROURACIL; MITOMYCIN C;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; TREATMENT OUTCOME; VAGINA CANCER;

ADULT; AGED; AGED, 80 AND OVER; ANTIBIOTICS, ANTINEOPLASTIC; ANTIMETABOLITES, ANTINEOPLASTIC; BRACHYTHERAPY; FEMALE; FLUOROURACIL; HUMANS; MIDDLE AGED; MITOMYCIN; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VAGINAL NEOPLASMS;

EID: 0032726287     PISSN: 00048461     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1673.1999.00715.x     Document Type: Article

References (15)

1. 1. Lee RW, Marcus RB, Sombeck MD. Radiotherapy alone for carcinoma of the vagina: The importance of overall treatment time. Int J Radiat Oncol Biol Phys 1994; 29: 983-8.
2. 2. Miller BA, Ries LAG, Hankey BF et al. (eds). Cancer Statistics Review: 1973-89. National Cancer Institute NIH Pub No 92-2789, Bethesda, 1992.
3. 3. Spirtos NM, Doshi BP, Kapp DS, Teng N. Radiation therapy for squamous cell carcinoma of the vagina: Stanford University experience. Gynecol Oncol 1989; 35: 20-6.
4. 4. Dixit S, Singhal S, Baboo HA. Squamous cell carcinoma of the vagina: A review of 70 cases. Gynecol Oncol 1993; 48: 80-7.
5. 5. Ball HG, Bereman ML. Management of primary vaginal carcinoma. Gynecol Oncol 1982; 14: 154-63.
6. 6. Chyle V, Zagars G, Wheeler JA, Wharton JT, Delclos L. Definitive radiotherapy for carcinoma of the vagina: Outcome and prognostic factors, Int J Radiat Oncol Biol Phys 1996; 35: 891-905.
7. 7. Kosary CL. FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynaecological system: An analysis of the 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva and vagina. Semin Surg Oncol 1994; 10: 31-46.
8. 8. Urbanski K, Kojs Z, Reinfuss M, Fabisiak W. Primary invasive vaginal carcinoma treated with radiotherapy. Analysis of prognostic factors. Gynecol Oncol 1996; 60: 16-21.
9. 9. Kirkbride P, Fyles A, Rawlings GA et al. Carcinoma of the vagina: Experience at the Princess Margaret Hospital (1974-89). Gynecol Oncol 1995; 56: 435-43.
10. 10. Spirtos NM, Doshi BP, Kapp DS, Teng N. Radiation therapy for primary squamous cell carcinoma of the vagina: Stanford University experience, Gynecol Oncol 1989; 35: 20-6.
11. 11. Leung S, Sexton M. Radical radiation therapy for carcinoma of the vagina: Impact of treatment modalities on outcome. Peter MacCallum Cancer Institute Experience 1979-90. Int J Radiat Oncol Biol Phys 1993; 25: 413-18.
12. 12. International Federation of Gynecology and Obstetrics. Classification and staging of malignant tumours of the female pelvis. Acta Obstet Gynecol Scand 1971; 50: 1-7.
13. 13. Oken MM, Creech RH, Torrney DC et al. Toxicity and response criteria of the Eastern Oncology Group. Am J Clin Oncol 1982; 5: 649-55.
14. 14. Chassagne D, Sismondi P, Horiot JC et al. A glossary for reporting complications of treatment in gynecological cancers. Radiother Oncol 1993; 26: 195-202.
15. 15. Fine BA, Piver MS, McAuley M, Driscoll D, The curative potential of radiation therapy in the treatment of primary vaginal carcinoma. Am J Clin Oncol 1996; 19: 39-44.